EU patient organizations deny pharma data disclosure mobilization
This article was originally published in SRA
Patient organizations in Europe have rejected claims that they are being "mobilized" by the pharmaceutical industry to lobby against moves by the European Medicines Agency that would make companies release clinical trial data.
You may also be interested in...
Draft guidelines due out for consultation this week in Italy are expected to shed more light on what companies will have to reveal during pricing and reimbursement negotiations.
Germany is for the first time to adopt national guidelines on prescribing biologics and biosimilars in a move towards increasing biosimilar uptake.
EFPIA, the European Federation of Pharmaceutical Industries and Associations, has put forward what it thinks the European regulatory network strategy to 2025 should prioritize.